ラクオリア創薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2018/05/08 | 1,536 | 1,614 | 1,520 | 1,590 | +48 | +3.1% | 724,000 |
2018/05/07 | 1,571 | 1,589 | 1,536 | 1,542 | -55 | -3.4% | 465,400 |
2018/05/02 | 1,557 | 1,608 | 1,555 | 1,597 | +29 | +1.8% | 328,200 |
2018/05/01 | 1,584 | 1,598 | 1,547 | 1,568 | -31 | -1.9% | 585,800 |
2018/04/27 | 1,623 | 1,627 | 1,589 | 1,599 | -11 | -0.7% | 444,400 |
2018/04/26 | 1,673 | 1,679 | 1,600 | 1,610 | -63 | -3.8% | 821,100 |
2018/04/25 | 1,623 | 1,697 | 1,619 | 1,673 | +44 | +2.7% | 550,200 |
2018/04/24 | 1,664 | 1,730 | 1,623 | 1,629 | -21 | -1.3% | 1,082,200 |
2018/04/23 | 1,617 | 1,657 | 1,585 | 1,650 | +33 | +2% | 573,500 |
2018/04/20 | 1,600 | 1,647 | 1,583 | 1,617 | +17 | +1.1% | 527,900 |
2018/04/19 | 1,630 | 1,637 | 1,575 | 1,600 | -21 | -1.3% | 710,000 |
2018/04/18 | 1,670 | 1,677 | 1,611 | 1,621 | -50 | -3% | 816,500 |
2018/04/17 | 1,642 | 1,709 | 1,605 | 1,671 | +51 | +3.1% | 1,201,300 |
2018/04/16 | 1,650 | 1,693 | 1,596 | 1,620 | -41 | -2.5% | 642,600 |
2018/04/13 | 1,640 | 1,682 | 1,620 | 1,661 | +26 | +1.6% | 639,200 |
2018/04/12 | 1,711 | 1,716 | 1,618 | 1,635 | -75 | -4.4% | 1,134,000 |
2018/04/11 | 1,781 | 1,831 | 1,701 | 1,710 | -84 | -4.7% | 1,619,200 |
2018/04/10 | 1,764 | 1,813 | 1,739 | 1,794 | +14 | +0.8% | 613,200 |
2018/04/09 | 1,732 | 1,801 | 1,725 | 1,780 | +8 | +0.5% | 712,600 |
2018/04/06 | 1,746 | 1,804 | 1,717 | 1,772 | +3 | +0.2% | 962,500 |
2018/04/05 | 1,750 | 1,789 | 1,700 | 1,769 | +57 | +3.3% | 946,800 |
2018/04/04 | 1,823 | 1,834 | 1,712 | 1,712 | -100 | -5.5% | 1,376,300 |
2018/04/03 | 1,792 | 1,824 | 1,772 | 1,812 | -20 | -1.1% | 929,600 |
2018/04/02 | 1,820 | 1,906 | 1,802 | 1,832 | +24 | +1.3% | 781,600 |
2018/03/30 | 1,850 | 1,851 | 1,774 | 1,808 | -28 | -1.5% | 1,108,900 |
2018/03/29 | 1,815 | 1,871 | 1,771 | 1,836 | +36 | +2% | 1,246,700 |
2018/03/28 | 1,749 | 1,832 | 1,740 | 1,800 | +24 | +1.4% | 954,400 |
2018/03/27 | 1,900 | 1,901 | 1,757 | 1,776 | -13 | -0.7% | 2,078,600 |
2018/03/26 | 1,722 | 1,808 | 1,647 | 1,789 | +43 | +2.5% | 1,635,200 |
2018/03/23 | 1,756 | 1,817 | 1,736 | 1,746 | -106 | -5.7% | 1,155,800 |
2018/03/22 | 1,820 | 1,863 | 1,785 | 1,852 | +10 | +0.5% | 986,700 |
2018/03/20 | 1,739 | 1,886 | 1,731 | 1,842 | +23 | +1.3% | 1,112,700 |
2018/03/19 | 1,906 | 1,919 | 1,768 | 1,819 | -107 | -5.6% | 1,245,000 |
2018/03/16 | 1,944 | 1,948 | 1,885 | 1,926 | -19 | -1% | 1,121,800 |
2018/03/15 | 1,996 | 2,006 | 1,938 | 1,945 | -56 | -2.8% | 1,520,900 |
2018/03/14 | 1,999 | 2,028 | 1,969 | 2,001 | -14 | -0.7% | 1,425,800 |
2018/03/13 | 2,029 | 2,092 | 2,001 | 2,015 | +26 | +1.3% | 2,939,300 |
2018/03/12 | 2,032 | 2,039 | 1,952 | 1,989 | -18 | -0.9% | 1,309,300 |
2018/03/09 | 2,005 | 2,070 | 1,970 | 2,007 | +22 | +1.1% | 2,206,800 |
2018/03/08 | 2,010 | 2,014 | 1,953 | 1,985 | +24 | +1.2% | 1,312,000 |
2018/03/07 | 2,019 | 2,055 | 1,945 | 1,961 | -95 | -4.6% | 1,762,200 |
2018/03/06 | 2,000 | 2,089 | 1,950 | 2,056 | +164 | +8.7% | 2,550,300 |
2018/03/05 | 2,056 | 2,121 | 1,890 | 1,892 | -185 | -8.9% | 2,846,900 |
2018/03/02 | 2,060 | 2,183 | 2,005 | 2,077 | -26 | -1.2% | 2,996,300 |
2018/03/01 | 2,100 | 2,160 | 2,074 | 2,103 | -67 | -3.1% | 2,629,400 |
2018/02/28 | 2,152 | 2,244 | 2,135 | 2,170 | +87 | +4.2% | 6,076,100 |
2018/02/27 | 2,168 | 2,177 | 2,008 | 2,083 | -73 | -3.4% | 4,230,800 |
2018/02/26 | 2,220 | 2,250 | 2,156 | 2,156 | -34 | -1.6% | 3,604,400 |
2018/02/23 | 2,240 | 2,269 | 2,140 | 2,190 | +4 | +0.2% | 7,473,400 |
2018/02/22 | 2,140 | 2,249 | 2,125 | 2,186 | +36 | +1.7% | 11,039,700 |
1601~
1650
件表示中 / 3268件
類似銘柄と比較する
現在ご覧いただいている「ラクオリア」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ラクオリア | 46,200円 | +138.6% | - | 0.00% | 42.35倍 | 1.78倍 |
|
ファイザー旧国内研究所が前身。導出した発売済み消化器薬等収益柱に成長、低分子創薬に強い |
ソレイジア | 5,000円 | +102.6% | - | 0.00% | - | 5.54倍 |
|
がん柱の創薬ベンチャー。候補品導入後に開発進め権利再導出、製品販売を行うビジネスモデル |
ペルセウス | 72,300円 | 0.0% | - | 0.00% | - | 6.06倍 |
|
東大発バイオベンチャー。高機能抗体の取得に強み。抗体医薬品や抗体薬物複合体(ADC)開発 |
モダリス | 14,100円 | - | - | 0.00% | - | 8.93倍 |
|
遺伝子治療薬の創薬ベンチャー、切断しない独自のゲノム編集技術に強み。研究開発中心は米国 |
仁 丹 | 211,400円 | +2.4% | +10.4% | 2.60% | 12.36倍 | 0.69倍 |
|
代名詞の仁丹から整腸作用軸に健康サプリ、医薬品へ展開。シームレスカプセル技術に特長 |
市場注目の銘柄
チャート関連のコラム